Delivery Order SPE2DR25D3501-SPE2DR26FL9YP
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 24, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pen injectors valued at $2,325.92, with completion targeted for October 27, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's broader pharmaceutical supply agreement with DLA. The product will be delivered to AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injectors valued at $3,164.74. This is a firm fixed-price delivery order with an ultimate completion date of December 9, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Trulicity 0.75 mg/0.5 ml pen injectors valued at $2,702.70, with completion scheduled for September 10, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is executed under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injectors with a ceiling value of $2,907.40. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The order is set for completion by November 7, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a $3,184.17 delivery order to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pen injectors on December 4, 2025, with an ultimate completion date of December 5, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pen injectors with a firm fixed price ceiling value of $4,263.41 and an ultimate completion date of November 7, 2025. This non-set-aside, competitively awarded delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,781.10 on August 8, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pen injectors with a completion date of August 11, 2025. This competitive award, which utilized firm fixed-price pricing with no set-aside designation, represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply framework. The product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,744.44 on November 20, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pen injectors (0.5 mL dosage). This firm fixed-price delivery order is scheduled for completion by November 21, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award was made competitively without any set-aside designation and represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pen injectors valued at $2,085.42 on October 27, 2025, with completion targeted for October 28, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitively awarded pharmaceutical supply transaction supporting federal medical procurement needs. The contract will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp on November 25, 2025, for the supply of Trulicity 0.75 mg/0.5 ml pen injectors, with a ceiling value of $1,105.64 and an ultimate completion date of November 26, 2025. The contract was competitively awarded without set-aside restrictions and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- SPE2DR25D3501Indefinite Delivery Contract
- SPE2DR25D3501-SPE2DR26FL9YPDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pen injectors valued at $1,381.44. This is a firm fixed price delivery order with an ultimate completion date of December 5, 2025, and represents a non-competitive set-aside award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026. The IDC enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, and medical devices across multiple therapeutic domains. Trulicity, a diabetes management medication, represents one of the specialized pharmaceutical products the contractor routinely delivers through this prime vendor arrangement to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 12/3/25 |